• LAST PRICE
    7.7300
  • TODAY'S CHANGE (%)
    Trending Up0.1000 (1.3106%)
  • Bid / Lots
    7.6000/ 2
  • Ask / Lots
    7.7700/ 19
  • Open / Previous Close
    7.4900 / 7.6300
  • Day Range
    Low 7.4900
    High 7.8399
  • 52 Week Range
    Low 2.2500
    High 8.5000
  • Volume
    305,112
    above average

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
1 Day Comparison Chart Accessibility Table. Friday's close: 7.63
TimeVolumeDCTH
09:32 ET13047.49
09:36 ET1507.5
09:38 ET119467.63
09:39 ET6267.65
09:41 ET4007.67
09:45 ET2007.655
09:48 ET76007.65
09:50 ET3687.65
09:52 ET10907.63
09:54 ET1487.64
09:57 ET12007.65
09:59 ET9007.65
10:03 ET16607.67
10:06 ET1007.65
10:10 ET5007.65
10:12 ET10007.65
10:15 ET1007.65
10:17 ET2007.65
10:19 ET4007.64
10:21 ET6007.64
10:24 ET3007.64
10:26 ET1007.64
10:30 ET6007.64
10:33 ET41537.65
10:35 ET1007.645
10:37 ET1007.645
10:39 ET18507.65
10:44 ET1007.67
10:46 ET1007.66
10:50 ET2207.64
10:53 ET1007.635
10:55 ET8107.635
11:00 ET17007.63
11:04 ET7007.65
11:08 ET4447.69
11:11 ET2007.6475
11:13 ET2007.6475
11:15 ET6007.65
11:18 ET19907.69
11:22 ET8007.659
11:27 ET39187.67
11:29 ET1007.6899
11:31 ET15297.645
11:33 ET2007.645
11:36 ET2007.65
11:40 ET1007.64
11:42 ET5007.65
11:44 ET3007.65
11:45 ET2007.65
11:47 ET2007.65
11:49 ET21007.63
11:51 ET2007.64
11:54 ET1007.64
11:58 ET4007.68
12:03 ET3007.645
12:05 ET2007.64
12:07 ET10007.65
12:09 ET11007.65
12:14 ET34957.65
12:25 ET1607.63
12:27 ET2007.65
12:30 ET15207.65
12:32 ET23677.65
12:34 ET3007.65
12:36 ET8007.65
12:38 ET6057.65
12:39 ET7627.65
12:43 ET2507.6653
12:50 ET10007.65
12:52 ET36007.655
12:54 ET1007.65
12:57 ET1007.65
12:59 ET57567.65
01:01 ET15007.65
01:03 ET14007.65
01:08 ET3007.65
01:12 ET11107.65
01:14 ET4007.66
01:15 ET30817.65
01:17 ET7507.6524
01:19 ET1007.65
01:21 ET15007.67
01:24 ET4207.665
01:26 ET1007.66
01:30 ET3007.65
01:37 ET7207.645
01:42 ET12307.66
01:44 ET37837.69
01:46 ET4007.71
01:51 ET10077.72
01:53 ET178767.73
01:57 ET273637.68
02:00 ET34227.68
02:02 ET73987.64
02:04 ET11007.67
02:06 ET23897.67
02:09 ET50797.7099
02:11 ET2007.7
02:15 ET1007.6825
02:20 ET16607.7
02:22 ET5157.68
02:27 ET1007.65
02:29 ET1007.65
02:33 ET7007.69
02:36 ET35267.71
02:38 ET88107.69
02:40 ET2007.66
02:42 ET50727.71
02:51 ET2007.69
02:58 ET12437.75
03:00 ET54037.75
03:02 ET30827.7736
03:05 ET1007.72
03:07 ET29977.75
03:09 ET15857.715
03:14 ET1007.69
03:18 ET145407.67
03:20 ET5007.69
03:21 ET27057.7
03:23 ET22187.7086
03:25 ET2007.71
03:32 ET25617.73
03:34 ET24247.73
03:38 ET19997.71
03:39 ET42717.74
03:41 ET6007.68
03:45 ET131537.81
03:48 ET1007.78
03:52 ET8007.73
03:54 ET2007.72
03:56 ET8497.72
03:57 ET7737.73
03:59 ET28817.73
Data delayed at least 15 minutes.
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesDCTH
Delcath Systems Inc
212.0M
-2.9x
---
United StatesSENS
Senseonics Holdings Inc
207.8M
-2.8x
---
United StatesCVRX
CVRx Inc
220.3M
-4.4x
---
United StatesUTMD
Utah Medical Products Inc
235.6M
14.8x
+2.27%
United StatesLUNG
Pulmonx Corp
224.0M
-3.8x
---
United StatesSMLR
Semler Scientific Inc
270.8M
13.9x
+31.99%
As of 2024-06-17

Company Information

Delcath Systems, Inc. is an interventional oncology company focused on the treatment of primary and metastatic liver cancers. The Company's products, HEPZATO KIT (Hepzato (melphalan) for Injection/Hepatic Delivery System) and CHEMOSAT Hepatic Delivery System for Melphalan (CHEMOSAT) percutaneous hepatic perfusion (PHP) are designed to administer high-dose chemotherapy to the liver while controlling systemic exposure and associated side effects during a PHP procedure. HEPZATO KIT is a drug/device combination product designed to administer high-dose chemotherapy directly into the liver while limiting systemic exposure and associated side effects. In Europe, the hepatic delivery system is a stand-alone medical device having the same device components as HEPZATO KIT, but without the melphalan hydrochloride and is approved for sale under the trade name CHEMOSAT. In the United States, HEPZATO is regulated as a drug by the United States Food and Drug Administration (FDA).

Contact Information

Headquarters
566 Queensbury AvenueQUEENSBURY, NY, United States 12804
Phone
518-743-8892
Fax
212-489-2102

Executives

Independent Chairman of the Board
John Sylvester
Chief Executive Officer, Director
Gerard Michel
Chief Operating Officer
Martha Rook
Executive Vice President - Global Head of Operations
John Purpura
Senior Vice President - Finance, Chief Accounting Officer, Executive Officer
Sandra Pennell

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$212.0M
Revenue (TTM)
$4.6M
Shares Outstanding
27.8M
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
0.62
EPS
$-2.65
Book Value
$0.69
P/E Ratio
-2.9x
Price/Sales (TTM)
46.0
Price/Cash Flow (TTM)
---
Operating Margin
-871.17%
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.